Clarus Wealth Advisors Pfizer Inc Transaction History

Clarus Wealth Advisors

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$46.53 - $55.17 $173,649 - $205,894	-3,732 Closed	0 $0
Q1 2022 Apr 12, 2022	SELL	$45.75 - $56.69 $121,649 - $150,738	-2,659 Reduced 41.61%	3,732 $201,000
Q3 2019 Oct 11, 2019	BUY	$32.49 - $42.13 $197,181 - $255,686	6,069 Added 1884.78%	6,391 $230,000
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $48,776 - $54,764	-1,319 Reduced 80.38%	322 $14,000
Q1 2019 Apr 04, 2019	BUY	$37.5 - $41.2 $4,350 - $4,779	116 Added 7.61%	1,641 $70,000
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $6,655 - $7,587	-173 Reduced 10.19%	1,525 $67,000
Q4 2018 Jan 08, 2019	BUY	$38.47 - $43.86 $65,322 - $74,474	1,698 New	1,698 $75,000
Q4 2018 Jan 07, 2019	SELL	$38.47 - $43.86 $65,322 - $74,474	-1,698 Closed	0 $0
Q3 2018 Oct 03, 2018	SELL	$34.47 - $41.81 $19,716 - $23,915	-572 Reduced 25.2%	1,698 $75,000
Q2 2018 Jul 05, 2018	BUY	$32.98 - $35.16 $74,864 - $79,813	2,270 New	2,270 $81,000
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $352,796 - $409,293	-11,056 Closed	0 $0
Q4 2017 Feb 05, 2018	BUY	$33.26 - $35.29 $367,722 - $390,166	11,056	11,056 $400,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.